| Cell line | Species | Tissue | Culture medium | Cencentration |
|---|---|---|---|---|
| 293 | human | kidney; fetal | Minimal essential medium | 2.50 (μg/ml) |
| A-431 | human | epidermis; epidermoid carcinoma | Dulbecco's modified Eagle's medium | 20 (μg/ml) |
| MCF 10A | human | mammary gland; fibrocystic disease | endothelial cell growth medium (EGM) | 5 (μg/ml) |
| 293 | human | kidney; fetal | Dulbecco's modified Eagle's medium | 2 (μg/ml) |
| NIH/3T3 | mouse | embryo | Dulbecco's modified Eagle's medium | 2 (μg/ml) |
| NIH/3T3 | mouse | embryo | Dulbecco's modified Eagle's medium | 2 (μg/ml) |
| WI-38 VA-13 subline 2RA | human | lung | Dulbecco's modified Eagle's medium | 5 (μg/ml) |
| 3T3-L1 | mouse | embryo | Dulbecco's modified Eagle's medium | 5 (μg/ml) |
| CHO | hamster, Chinese | ovary | Dulbecco's modified Eagle's medium | 10 (μg/ml) |
| CHO | hamster, Chinese | ovary | Ham’s F-12 nutrient mixture | 10 (μg/ml) |
| Jurkat, Clone E6-1 | human | T lymphocyte; acute T cell leukemia | RPMI 1640 Medium | 5 (μg/ml) |
| CHO-K1 | hamster, Chinese | ovary | Ham’s F-12 nutrient mixture | 5 (μg/ml) |
| H9 | human | RPMI 1640 Medium | 5 (μg/ml) | |
| B16-F1 | mouse | skin; melanoma | Dulbecco's modified Eagle's medium | 6.25 (μg/ml) |
| NIH/3T3 | mouse | embryo | Dulbecco's modified Eagle's medium | 25 (μg/ml) |
| NIH/3T3 | mouse | embryo | 50 (μg/ml) | |
| COS-1 | monkey, African green | kidney | Dulbecco's modified Eagle's medium | 5 (μg/ml) |
| HeLa | human | cervix; adenocarcinoma | Dulbecco's modified Eagle's medium | 10 (μg/ml) |
| HeLa S3 | human | cervix; adenocarcinoma | Dulbecco's modified Eagle's medium | 10 (μg/ml) |
| HeLa S3 | human | cervix; adenocarcinoma | Dulbecco's modified Eagle's medium | 10 (μg/ml) |
| BINE4.8 | RPMI 1640 Medium | 10 (μg/ml) | ||
| A-431 | human | epidermis; epidermoid carcinoma | Dulbecco's modified Eagle's medium | 0.6 (μg/ml) |
| A-431 | human | epidermis; epidermoid carcinoma | α-modified minimal essential medium | 5 (μg/ml) |
| Ba/F3 | RPMI 1640 Medium | 5 (μg/ml) | ||
| SW 1990 | human | spleen (metastasis); adenocarcinoma (pancreas primary) | RPMI 1640 Medium | 50 (μg/ml) |